Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane

Senti Biosciences in $645M Spark pact to drive gene circuits into the fast lane

Source: 
Fierce Biotech
snippet: 

Roche’s gene therapy unit Spark Therapeutics has penned a $645 million-plus biobucks pact with Bayer-backed Senti Biosciences for new tech aimed at tweaking next-gen gene therapies.